Sectra Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Sectra şirketinin toplam hissedar öz sermayesi SEK1.7B ve toplam borcu SEK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK3.2B ve SEK1.5B dir. Sectra 'in FAVÖK'ü SEK554.4M faiz karşılama oranı -26.7 dur. Şirketin SEK699.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranı	-26.7x
Nakit	SEK 699.36m
Eşitlik	SEK 1.65b
Toplam yükümlülükler	SEK 1.52b
Toplam varlıklar	SEK 3.17b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 61L0 'nin kısa vadeli varlıkları ( SEK2.4B ) kısa vadeli yükümlülüklerini ( SEK1.4B ) aşıyor.

Uzun Vadeli Yükümlülükler: 61L0 şirketinin kısa vadeli varlıkları ( SEK2.4B ) uzun vadeli yükümlülüklerini ( SEK73.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 61L0 borçsuzdur.

Borcun Azaltılması: 61L0 şirketinin 5 yıl önce borç/öz sermaye oranı 0.9% iken borcu yok.

Borç Kapsamı: 61L0 un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 61L0 şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Sectra Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

High number of new directors

First quarter 2025 earnings released: EPS: kr0.42 (vs kr0.32 in 1Q 2024)

Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023)

Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023)

Sectra AB (publ) to Report Fiscal Year 2025 Results on Jun 05, 2025

Sectra Adds It Solution for Genomics in Cancer Diagnostics-First Deployment At A Us Health System

Sectra and Leica Biosystems Gains FDA Clearance to Utilize DICOM Images for Pathology Diagnostics

Sectra AB (publ) to Report Nine Months, 2025 Results on Mar 14, 2025

Third quarter 2024 earnings released: EPS: kr0.30 (vs kr0.38 in 3Q 2023)

Sectra AB (publ) to Report Q1, 2025 Results on Sep 06, 2024

Investor sentiment improves as stock rises 21%

Sectra AB (publ), Annual General Meeting, Sep 10, 2024

Second quarter 2024 earnings released: EPS: kr0.78 (vs kr0.49 in 2Q 2023)

Upcoming dividend of kr1.10 per share at 0.9% yield

First quarter 2024 earnings released

Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022)

New minor risk - Share price stability

Sectra AB (Publ) Proposes Dividend

Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022)

Third quarter 2023 earnings released

Sectra AB (publ), Annual General Meeting, Sep 07, 2023

Second quarter 2023 earnings released

Sectra AB (Publ) Elects Ulrika Unell to the Board

First quarter 2023 earnings released

Sectra Launches Next Generation Cloud Portal to Enhance Clinical Learning in Medical Education

Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021)

Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021)

Sectra AB (Publ) Proposes Dividend

Sectra AB (publ) to Report Nine Months, 2023 Results on Mar 10, 2023

High number of new directors

Third quarter 2022 earnings: Revenues exceed analyst expectations

Independent Director recently bought €91k worth of stock

Second quarter 2022 earnings: Revenues miss analyst expectations

High number of new directors

High number of new directors

First quarter 2022 earnings released: EPS kr1.90 (vs kr0.44 in 1Q 2021)

Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020)

Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020)

Chief Financial Officer recently bought €12k worth of stock

Third quarter 2021 earnings released: EPS kr1.39 (vs kr2.06 in 3Q 2020)

Revenue misses expectations

Sectra Signs Five-Year Enterprise Imaging Contract with Emory Healthcare in the US

Quantum-Proof Crypto from Sectra Receives SECRET Approval from EU

New 90-day low: €65.40

Sectra AB (publ) to Report Q1, 2022 Results on Sep 03, 2021

EU Orders Sectra Tiger Solution for Sharing Classified Information

Sectra AB (Publ) Receives an Order for its Digital Pathology Solution from Amsterdam UMC in the Netherlands

Sectra Receives Order from Institut Bergonié

Healthcare Region Pioneering Digital Pathology Reviews in Denmark with Sectra-Aims to Significantly Shorten Cancer Turn-Around Times

The Pennine Acute Hospitals NHS Trust Deploys the Imaging IT Solution from Sectra

Norwegian Healthcare Region Appoints Sectra as Enterprise Imaging Vendor for Efficient Region-Wide Patient Care

Insider recently bought €10.0k worth of stock

Sectra Signs Subscription-Based Enterprise Imaging Contract with Dayton Children's Hospital in US

Sectra and RSA Biomedical sign distribution agreement for Sectra's CT-based method for clinical validation of orthopaedic implant stability

Second quarter 2021 earnings released: EPS kr1.89

Revenue beats expectations

Sectra to Add its Digital Pathology Module to the Sectra Enterprise Imaging Solution

Sectra Signs A Digital Pathology Contract with the Helse Vest

Sectra Deploys Its Software for Medical Imaging At Leeds Teaching Hospitals

Sectra's Digital Pathology Solution Used in Training of Pathologists in Australasia

Amsterdam UMC Chooses Sectra for Enterprise-Wide Radiology Imaging

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin